X

Download Membrane antibodies=Academia Sinica PowerPoint Presentation

SlidesFinder-Advertising-Design.jpg

Login   OR  Register
X


Iframe embed code :



Presentation url :

Home / Health & Wellness / Health & Wellness Presentations / Membrane antibodies=Academia Sinica PowerPoint Presentation

Membrane antibodies=Academia Sinica PowerPoint Presentation

Ppt Presentation Embed Code   Zoom Ppt Presentation

PowerPoint is the world's most popular presentation software which can let you create professional Membrane antibodies=Academia Sinica powerpoint presentation easily and in no time. This helps you give your presentation on Membrane antibodies=Academia Sinica in a conference, a school lecture, a business proposal, in a webinar and business and professional representations.

The uploader spent his/her valuable time to create this Membrane antibodies=Academia Sinica powerpoint presentation slides, to share his/her useful content with the world. This ppt presentation uploaded by onlinesearch in Health & Wellness ppt presentation category is available for free download,and can be used according to your industries like finance, marketing, education, health and many more.

About This Presentation

Slide 1 - Membrane-bound antibodies for therapy and imaging Steve Roffler Institute of Biomedical Sciences Academia Sinica Taipei, Taiwan
Slide 2 - Immune cell regulation Prodrug Activation Gene expression imaging Localized cytokine expression Surface expression of biologically-active proteins Metabolic regulation cytokine antibody enzyme
Slide 3 - scFv Single-chain antibody receptors Liao et al., Biotechnology & Bioengineering (2001) 73, 313-323
Slide 4 - Gilliland et al., Tissue Antigens. 1996 47:1-20 Making a scFv from a hybridoma
Slide 5 - http://www.ibms.sinica.edu.tw/~sroff/protocols/scFv.htm Making a scFV from a hybridoma II
Slide 6 - Expression of scFv with commercial pHook-1 vector
Slide 7 - Enhancing surface expression transmembrane domains
Slide 8 - t1/2 12.2 3.8 2.4 1.6 h B7-1 DAF ASGPR PDGFR AFP-B7 is more stable on the cell surface Surface expression: B7 > DAF >> PDGFR = ASGPR Summary of AFP-TM results AFP-B7 is most rapidly transported to the cell surface cyt Import to ER Protein of interest Anchor in plasma membrane Epitope tag Epitope tag B7 TM is good for surface expression B7-1 CD80 DAF decay- accelerating factor ASGPR asialoglycoprotein receptor PDGFR platelet-derived growth factor receptor
Slide 9 - Linker domains increase surface expression Effect of linker domains on scFv receptor expression Liao et al., Cancer Gene Therapy (2003) 10: 779-790
Slide 10 - IP of culture medium Glycosylation controls surface shedding Carbohydrate chains reduce shedding and enhance surface expression protein expression surface expression GPI anchor glycosylated no glycosylation
Slide 11 - Activation of T cells by surface anti-CD3 scFv Defects or down-regulation TAP-1 TAP-2 Beta 2-microglobulin MHC class I heavy chain proteosome subunits
Slide 12 - Early events in T-cell activation Direct CD3 ligation can initiate T cell activation
Slide 13 - T cells can bind to cells that express anti-CD3 scFv
Slide 14 - . Anti-CD3 scFv activity anti-CD3 scFv can induce CTL activity anti-CD3 scFv with CD86 stimulates IL-2 secretion Anti-CD3 scFv is active in vitro
Slide 15 - anti-CD3 scFv with CD86 prevented growth of poorly immunogenic tumors in 45% of mice Tumor sizes in mice injected with B16-F1 transfectants
Slide 16 - Development of systemic anti-tumor immunity in tumor-free mice Long-term protective immunity was established by anti-CD3 and CD86 Original tumor B16/F1 rechallenge (tumor-free/total) B16/aCD3 + CD86 4/4 naive 0/4
Slide 17 - anti-CD28 scFv receptor scFv (aCD28) TM (B7) Linker(eB7) Is anti-CD28 scFv better than CD86? Can bind CD28 but not CTLA-4
Slide 18 - Tumor sizes after adenoviral therapy anti-CD3 with anti-CD28 delayed tumor growth 0 10 20 30 0 500 1000 1500 2000 Days Tumor size (mm 3 ) 0 10 20 30 0 500 1000 1500 2000 Days 0 10 20 30 0 500 1000 1500 2000 Days 0 10 20 30 0 500 1000 1500 2000 Days 0 10 20 30 0 500 1000 1500 2000 Days Tumor size (mm 3 ) 0 10 20 30 0 500 1000 1500 2000 Days 0 10 20 30 0 500 1000 1500 2000 Days control anti-phOx anti-CD3 + anti-CD28 anti-phOx + anti-CD28 anti-phOx + CD86 anti-CD3 + CD86 anti-CD3 1/7
Slide 19 - Goal: Develop membrane-anchored chimeric proteins that can be employed for both gene-expression imaging and therapy Single-gene for imaging and therapy
Slide 20 - green fluorescent protein luciferase herpes simplex type 1 virus thymidine kinase cytosine deaminase –galactosidase dopamine D2 receptor transferrin receptor High selectivity, but immunogenic Low immunogenicity, but less selective Reporter genes Exogenous genes Endogenous genes
Slide 21 - Antibody-hapten imaging of transgene expression Advantages of antibody/hapten system Low immunogenicity (human or humanized Ab) High specificity and affinity Hydrophilic probes (small volume of distribution) anti-hapten scFv Cell Hydrophilic probe
Slide 22 - DNS probes for gamma camera imaging dansyl phOx Roffler et al., Gene Ther., 13:412-20, 2006
Slide 23 - In vivo accumulation of radioactive DNS-probe The DNS probe was retained at tumors that express DNS scFv on their surface
Slide 24 - In vivo imaging anti-phOX tumor Mouse 1 Mouse 2 #1 #2 anti-DNS tumor 1 h 24 h 48 h #1 #2 #1 #2 Dansyl probe allowed imaging of DNS-positive tumors in mice
Slide 25 - Hapten-directed therapy anti-DNS scFv Prodrug: Reduce tumor size/generate antigens IL-2: Stimulate antitumor immunity
Slide 26 - Binding of hapten-modified proteins to anti-DNS scFv on cells DNS-labeled proteins selectively bound to anti-DNS scFv on CT-26 cells
Slide 27 - Activity of DNS-PEG-IL-2 DNS-PEG-IL-2 is active when retained by anti-DNS scFv on CT-26 cells
Slide 28 - Prodrug activation by DNS-PEG-bG DNS-PEG-bG can activate HAMG at CT-26/DNS cells
Slide 29 - In vivo localization of DNS-PEG-bG at CT-26/DNS tumors DNS-labeled bG can accumulate at CT-26/DNS tumors
Slide 30 - None of the treatments delayed the growth of CT-26/phOx tumors Combination therapy of CT-26/DNS tumors Combined treatment was more effective than single agent therapy Chuang et al., Bioconjugate Chem., 17: 707-714, 2006.
Slide 31 - Institute of Biomedical Sciences Academia Sinica
Slide 32 - Dr. Kuang-Wen Liao Tang-Bi Liu Surface scFv T cell activation Surface expression Shih-en Chang Bing-Mae Chen Dr. Yu-Ling Leu Chia-Nan College of Pharmacy and Science Dr. Ji-Wang Chern National Taiwan University Dr. Tian-Lu Cheng Kaohsiung Medical University Chin-Chuan Chen Dr. Hsin-Ell Wang National Yang Ming University Yi-Hsuan Chiang Chien-I Su Joseph Lee Jill Lin
 

Frequently Asked Questions

> About SlidesFinder?

Slidesfinder is a website that allows users to upload and share their PowerPoint presentations online. It provides a platform for individuals and businesses to share their ideas and knowledge through presentations, and for others to view and download these presentations for educational or professional purposes.
Slidesfinder offers a wide range of presentation topics and categories, including business, education, science, technology, health, and more. Users can also search for presentations using keywords, tags, or by category. The website provides tools to create professional presentations with rich media, animations, and graphics.



One of the key features of Slidesfinder is its user-friendly interface, which allows users to easily upload, view, and share presentations. Users can also embed their presentations in their websites or blogs using the website's embed code feature.
Slidesfinder also offers premium services, such as the ability to create private presentations and to download presentations in high-quality formats. However, the basic features of Slidesfinder are free to use, making it accessible to anyone who wants to share their ideas and knowledge through presentations.

> How do I register with SlidesFinder?

Go to registration page (you can see signup link on top of website page) https://www.slidesfinder.com/signup . If you have facebook/gmail account them just click on SIGN IN WITH FACEBOOK OR SIGN IN WITH GOOGLE button, by this you will be a registered member of slidesfinder without filling any form, required detail automatically will be fatch from your account. If you do not a Facebook account, then click on "Signup". Fill all required fields and you will be a registered member of slidesfinder.

> Is slidesfinder account confirmation is mandatory?

Yes it is mandetory to active your account to login.

> Do I need to signup/login on SlidesFinder before uploading a PowerPoint presentation?

Yes, you need to login with your account before uploading presentation. Your username will be displayed on your uploaded presentation. Your registered email id is needed for sending your stats of uploaded presentation.

Slidesfinder is a sharing website for PowerPoint presentations search and share. Find your interest in the form of powerpoint presentations on slidesfinder and save your valuable time . On Slidesfinder you get presentations from our huge library of professional ppt presentations. We believe in making your search INFORMATIVE and FUN. Find your best ppt presentation from a pool of PowerPoint presentations stacked under important industry categories like business & management, heath & Wellness,eduction & training etc. We provide unique informative PowerPoint presentation for marketers, presenters and educationists. These professional PowerPoint presentations are uploaded by professionals from across numerous industry segments.These ppt presentations are available for FREE download.

Not just finding your interest, but facilitate you broadcast your interest. We have created this platform for easy sharing of PowerPoint presentations, ensuring that these presentations get maximum exposure. Create your slidesfinder account and upload PowerPoint presentations for free, share on social media platforms and BUILD YOUR CROWD WITH PRESENTATION !!

The Great Buddha says, "Share your knowledge.It’s a way to achieve immortality"! So, start sharing knowledge and we are here to make that immortal !!

© 2013-2024 SlidesFinder. All rights reserved.

Re-productivity of content are not allowed. Without prior written permission from author, commercial use of any content is illegal.